More than one thousand delegates are expected to converge on Auckland’s new conference centre for a highly-anticipated Blood 2026, with a scientific program showcasing the latest innovations across ...

An updated international consensus on type 2 diabetes management has broadened the focus from glycaemic control alone to the prevention of long-term complications with the help of emerging therapies.

ADHD and autism is particularly prevalent among young people diagnosed with type 2 diabetes before the age of 20, according to data presented at the EASD annual meeting. The analysis used TriNetX US ...

Lowering B-cell burden and systemic inflammation may reduce the risk of cytokine release syndrome (CRS) following CAR T-cell therapy in patients with autoimmune disease, new research suggests. The ...

Clinicians who fail to manage commercial conflicts of interest when treating patients face fines up of to $120,000, Ahpra has warned. The regulator has published new interim guidance for practitioners ...

Oncologists who receive payments from drug manufacturers are more likely to prescribe the company’s promoted cancer treatment, regardless of whether the treatment fits the relevant clinical guideline, ...

Two gastroenterologists have agreed to repay a combined $124,000 in Medicare rebates after admitting to inappropriate billing practices, such as scheduling colonoscopies and H. pylori screening ...

Triple agonist therapy retatrutide delivers mean weight reductions of more than 20% at the highest dose for patients with type 2 diabetes, results presented at the European Association for the Study ...

Australia’s physician training pathway is a major contributor to the regional specialist workforce crisis because it forces doctors from the country to relocate to major cities, where they are more ...

The editorial leadership of Diabetes Care is promoting a boycott of the American Diabetes Association’s 2027 conference, months after five senior physicians including its editor-in-chief Professor ...

A combined ERS/ TSANZ Task Force has delivered a summary of current knowledge in the management of reproduction and pregnancy in women with asthma, cystic fibrosis and non-CF bronchiectasis. While ...

The Minister for Health and Ageing Mark Butler has announced dapagliflozin (Forxiga, Astrazeneca) will be available on the PBS to more Australians living with CKD. It comes after the Pharmaceutical ...